Next Article in Journal
Metabolite Diversity and Carbohydrate Distribution in Brassica campestris ssp. chinensis L. Cultivars: A UPLC-MS/MS Approach
Next Article in Special Issue
Effects of Extended Treatment with Protium heptaphyllum Liposomes on Metabolic Parameters of Obese Rats
Previous Article in Journal
Information Load from Neuromediator Diffusion to Extrasynaptic Space: The Interplay between the Injection Frequency and Clearance
Previous Article in Special Issue
Effect of Liposomal Protium heptaphyllum (Alb.) March Extract in the Treatment of Obesity Induced by High-Calorie Diet
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Correlation of Adiponectin and Leptin with Anthropometrics and Behavioral and Physical Performance in Overweight and Obese Chinese College Students

1
Sports and Health Research Center, Department of Physical Education, Tongji University, Shanghai 200092, China
2
International College of Football, Tongji University, Shanghai 200092, China
3
Department for Quality of Life Studies, Bologna University, 40127 Bologna, Italy
*
Author to whom correspondence should be addressed.
Biology 2024, 13(8), 567; https://doi.org/10.3390/biology13080567
Submission received: 30 June 2024 / Revised: 17 July 2024 / Accepted: 20 July 2024 / Published: 27 July 2024
(This article belongs to the Special Issue Physiology and Pathophysiology of Obesity)

Abstract

:

Simple Summary

We studied a population of overweight and obese Chinese university students. Obesity, which was previously limited to the Western world, has emerged in Asia and China in recent years. Owing to the massive population of the Asian region, even effects on a small percentage of this population correspond to substantial problems. University students are an at-risk group for obesity due to the sedentary lifestyle imposed by their heavy study schedule. We measured the physical capacities, as well as several biochemical and behavioral variables, of Chinese students. We measured the blood levels of two multifunctional hormones, namely leptin (LEP) and adiponectin (ADPN), and levels of physical activity. We found that in obese students, physical capacities are linked with the hormone ADPN, which has been hypothesized to be linked with muscle development. We also found that sleep was associated with the blood levels of LEP and ADPN. To the best of our knowledge, our study is the first work to provide data on the association of LEP and ADPN with behavioral, physical, and biochemical variability in overweight and obese Asian populations. Such an association has potential for use as a comparison tool.

Abstract

The aim of this study is to assess the relationship of leptin (LEP) and adiponectin (ADPN) with other circulating fat markers, physical capacity, behaviors, and anthropometric indices in a population of overweight and obese Chinese university students. LEP and ADPN levels, as well as behavioral, anthropometric, biochemical, and performance characteristics, were measured. Method: A total of 17 anthropometric parameters, 8 questionnaires (investigating quality of life, sleep, eating, perceived functioning, stress, and depression), 9 biochemical parameters, and 12 functional parameters were investigated. Results: In contrast to previous studies, our work found an unusually strong relationship between LEP and ADPN (r = 0.961, p = 0.000) that can be related to ethnicity. We also found that LEP and ADPN were associated with stress and bodily pain. A total of 12 anthropometric measures were also associated with LEP/ADNP levels. Moreover, LEP and ADPN were found to be related to lower limb, hand, and abdominal strength; blood pressure; and basic metabolism. However, we did not find associations with sleep; eating habits; or cardiovascular fitness, which was measured in the form of resting heart rate and VO2max. Conclusion: This study reveals new relationships of LEP and ADPN with selected anthropometric and behavioral parameters in obese Chinese college students.

1. Introduction

Leptin [1,2] (LEP) and adiponectin [3] (ADPN) are two adipocytokines that have been widely studied in connection with obesity [4]. LEP increases and ADPN decreases with increasing body fat. The ADPN:LEP ratio is a prognostic factor for the development of obesity [5], cardiovascular disease [6], insulin resistance [7], and diabetes [8], as well as several other conditions, due to the ubiquity of LEP and ADPN in the human body [1,2]. Given that they are produced by adipose tissues, plasma LEP and ADPN have been connected with different anthropometric measures in the Caucasian population, particularly with waist and hip circumference, waist:hip ratio, BF%, and body fat mass [9]. By contrast, in the Asian population, plasma LEP and ADPN are connected with abdominal fat [10,11,12,13,14]. The relationship of LEP and ADPN with anthropometric measures is of clinical interest because it may aid in the diagnosis of hyperleptinemia, which has been widely explored [15,16]. Considering the proximity of LEP receptors to neuropeptide Y receptors in the hypothalamus [17], LEP has been studied in connection with anxiety, stress [18,19,20], depression [21,22,23], sleep [24], and eating behaviors [23,25]. LEP and ADPN levels have also been associated with behavioral factors, such as physical activity levels [25,26]. Although LEP and ADPN, as ergogenic molecules, have been suggested as markers of training status [27] in athletes, only a few studies on the possible link of LEP with the capacity for physical performance exist. In children, LEP is inversely correlated with the amount of physical activity [28] and positively correlated with VO2max [29]. However, the relationships of LEP and ADPN with physical performance in obese adults have been poorly investigated [30]. To the best of our knowledge, no studies exist on the relationship of LEP and ADPN with basic physical performance (lower limb, hand, and abdominal muscle strength; balance; and flexibility) in overweight/obese Asian college students. Furthermore, studies investigating behavioral, physical, biochemical, and anthropometric indices in the same cohort of overweight and obese subjects do not exist.
As suggested by the literature [10,11,12,13,14], the associations of LEP and ADPN with anthropometrics in Asians are different from those in Caucasians. Comparing different populations within the same BMI range revealed that ADPN concentrations were lower in the Indonesian population than in the Dutch population [31]. In obese Caucasians, LEP and ADPN showed no or low correlations with each other [32]. LEP has been hypothesized to be connected with different behaviors [33]. It regulates food intake, reward, and motivation. Reduced LEP impairs cognition [33].
To the best of our knowledge, only a few studies have linked LEP and ADPN with behavioral characteristics in Chinese populations. Behavior and LEP levels have been studied in Chinese schoolchildren. LEP was found to be associated with low math scores and high verbal scores. Low ADPN was found to be correlated with family-related behavioral problems [34]. LEP has been proposed as a biomarker of sleep disorders given that it acts as a mediating factor between obesity and poor sleep [35]. High ADPN and low LEP levels were associated with anxiety [36] and stress [37]. Therefore, our aim is to assess the relationship of LEP and ADPN with other circulating fat markers, physical capacity, behaviors, and anthropometric indices in a population of overweight and obese Chinese university students.

2. Materials and Methods

2.1. Participants

This study was a randomized, controlled trial. Obese and overweight adults were recruited from Tongji University through workshops, leaflets, social media, official web pages, and paper bulletins disseminated on campus.
The ethics committee of Tongji University approved all interventions (tjdxsr046). A total of 40 respondents were invited to visit the research department. Prior to the collection of eligibility data, researchers carefully explained the purpose and protocol of the study in detail. Prior to registration, participants signed a written informed consent letter. All participants completed an initial screening by filling out questionnaires on background information (including brief sedentary questions, medical history, current health status, a food intake questionnaire [FFQ25 [38]], the International Physical Activity Questionnaire [IPAQ [39]], and a physical examination). A total of 8 participants did not meet the inclusion criterion of sedentary obesity, and out of the 32 participants who were invited to enroll in this study, 6 refused. This study included 26 subjects (3 females) from different colleges of Tongji University in Shanghai (age 19.23 ± 1.39 years) (Table 1). Obesity was defined in accordance with Chinese reference values [40] as BMI > 28.

2.2. Inclusion and Exclusion Criteria

The inclusion criteria were (1) being apparently sedentary in accordance with living a sedentary lifestyle (spending more than 8 h awake in a sitting position daily and continuously sitting still for over 90 min); (2) age between 18 and 25 years; (3) BMI ≥ 25; (4) has not engaged in regular exercise for more than 30 min for 3–5 months; and (5) IPAQ score < 600 metabolic equivalents·min/week. Out of 26 subjects, 15 were obese (BMI > 28).
The exclusion criteria included (1) severe cardiovascular or skeletal muscle disease; (2) diabetes complications (such as postexercise hypoglycemia or autonomic neuropathy or peripheral neuropathy); (3) diagnosed with mental illnesses; and (4) other sports/exercise contraindications (diagnosed with heart problems). All the students regularly consumed their meals at the campus canteen.

2.3. Measurements

2.3.1. Anthropometric Measures

A total of 16 anthropometric measures were taken in accordance with standard procedures [41]. In total, 11 circumferences (chest; minimum and maximal waist line; contracted and relaxed hip, thigh, calf, and biceps brachii), and 6 skinfolds (shoulder and tight crease, biceps, abdominal, iliac, and calf) were measured. Weight, fat, fat-free and muscle masses, and body fat% were measured with a X-SCAN PLUS (Selvas, Gyeong, Republic of Korea) bioelectric impedance scale. Height was measured by using a Hengkang Jiaye (Shenzhen, China) anthropometer. Physical tests, including 1 min sit-ups and squats, standing on one leg with eyes closed, and the sit-and-reach test, were performed in accordance with ACSM guidelines [42].

2.3.2. Biochemical Parameters

Biochemical parameters were measured in duplicate after overnight fasting for at least 10 h. The following parameters were measured with the fully automated biochemical analyzer Dimension EXL 200, (Siemens Healthineers, Munchen, Germany): total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein, glucose, hemoglobin, and HbA1c. ADPN and LEP were quantified by using an E-EL-H0004-96 T human ADP/Acrp30 (ADPN) ELISA kit (BLKAZ5BYNR, Elabscience, Wuhan, China) and E-EL-H0113-96 T human LEP ELISA kit (EKF8PFBUAG, Elabscience, Wuhan, China) in accordance with the manufacturer’s instructions.

2.3.3. Cardiorespiratory Indices

Basal VO2, VO2max, and basal metabolism (METS) were measured on the basis of the mean of the FatMax test results. FatMax is the optimal heart rate for fat utilization [43]. Subjects were asked to refrain from vigorous exercise for 24 h and fast for 10 h before the test. All FatMax tests were conducted in the morning between 8 a.m. and 12 a.m. to avoid circadian variance. A graded treadmill exercise test was used to perform the FatMax test. In brief, a walking warm-up was performed at 3.0 km/h with an incline of 1% for 3 min. Subsequently, the first stage of exercise was performed at a speed of 6.0 km/h for 2 min. Each increase in speed had a duration of 2 min. The protocol was modified to adapt to the physical capacities of the sample from a previous study employing FatMax on obese adults [44]. The speeds of the following steps were 7.0, 8.0, 9.0, and 10 km/h until the respiratory exchange ratio of 1.15 was reached or the subject became exhausted. VO2 and VCO2 were measured by using a portable metabolic system (K5, COSMED, Rome, Italy) and Polar H10 (Polar Electro, Tampere, Finland) heartrate band. The test was stopped immediately if the subject showed symptoms of dizziness, nausea, or dyspnea during the test. Vital capacity was measured with an electronic activity tester (Hengkang Jiaye, Shenzhen, China).

2.3.4. Physical Performance Parameters

Diastolic and systolic blood pressure levels were measured with a standard sphygmomanometer, and resting heart rate was measured with a Polar H10 HR monitor. The grip strength of both hands was measured with a Jamar dynamometer. Progressive maximal contractions were performed for both hands, and the best value of 3 attempts was retained. All subjects were right-handed (Table 1).

2.3.5. Scale Evaluation

SF36 [45] quality of life; the IPAQ scale [39], which was also validated for blood pressure [46]; HAMA for anxiety and depression [47,48] (mental and body anxiety and total scores); PSS for perceived stress levels [49]; SDS for anxiety [50]; TFEQR21 for eating behaviors [51,52]; FS14 [53] (physical and mental fatigue and total scores); and PSQI [54] for the assessment of sleep were used. The SF-36 measures 8 scales: physical functioning (PF), physical role, bodily pain (BP), general health, vitality, social functioning (SF), emotional role, and mental health. Questionnaires were submitted in the form of the Chinese version validated in previous studies [45,46,47,48,49,50,51,52,53,54]. All measurements were performed in the morning, and the testing order was randomized between subjects for each test by using a random number sorter.

2.3.6. Statistical Analysis

Descriptive statistic and correlation analyses (Spearman) were performed by using SPSS IBM, SPSS Statistics 25. Levine and Shapiro–Wilk tests were used to check the homogeneity of variance and normality of data, respectively. All data were normally distributed. The extracted data included the mean and SD of participant characteristics, cardiorespiratory indices, and questionnaire scores.

3. Results

3.1. Sample Descriptive Statistics

Table 1 reports the means and standard deviations of the observed variables.

3.2. Questionnaires Scores

The questionnaire results of overweight and obese Chinese college students are reported in Table 2.
The mean PSQI score of our sample was within the range of normal sleep (0–5 points). However, we observed 10 subjects with a score between 6 and 10 (mild insomnia) and 1 subject with moderate insomnia (>10). The HAMA total cut-off point for anxiety disorders was 14. The mean of our subjects was below the anxiety threshold (6 subjects were beyond the threshold). The maximum FS14 fatigue score was 14. Our group average showed that our subjects, with the exception of 8 subjects who scored >10, did not perceive considerable fatigue. Our sample had a score of <50 on the SDS scale (no depression symptoms).

3.3. Correlations among Measured Variables

Table 3 reports the results of the correlation analysis. In contrast to several other studies [32,55,56,57], our work found that LEP and ADPN were strongly correlated with each other (r = 0.961, p = 0.000). As expected, LEP and ADPN were correlated with all other biochemical indices of fat metabolism that we measured (Table 3), with LEP showing an inverse correlation and ADPN a strong positive correlation with total cholesterol. LEP is correlated with LDL and HbA1c, and LEP and ADPN were correlated with HGB. In agreement with another study on obesity that found a CC of 0.670 (p = 0.0001) [58], this work discovered that ADPN was correlated with HDL (Table 3). ADPN showed a correlation with BMI; height; hip, bicep (contracted and relaxed), waist, and calf circumferences; shoulder crease skinfolds; and waist:hip ratio and muscle mass. LEP presented correlations with the previous variables, except for muscle mass, fat-free mass, waist circumferences, and shoulder crease skinfold. However, in contrast to ADPN, LEP showed a correlation with thigh circumference (Table 2). ADPN was correlated with muscle and fat-free masses, 1 min squat (reps), long jump, 1 min sit-up (reps), and hand grip but not with sit-and-reach test results and body balance. LEP exhibited the same correlations with physical performance (Table 2).
Although previous studies also observed a correlation between LEP and blood pressure in obese individuals with high blood pressure [59], our sample did not appear to have hypertension. METS was also correlated with LEP and ADPN. LEP was correlated with the total score on the PSQI questionnaire and with the PF and BP subscales of SF36. LEP and ADPN were correlated with the depression and stress scales, as well as with the BP and physical function scales (Table 3).

4. Discussion

Low (or decreased) levels of LEP and high (or increased) levels of ADPN are beneficial in terms of reducing weight and inflammation and desirable in overweight and obese individuals [3]. The present study aims to explore the relationships between LEP and ADPN in obese Chinese university students. Considering the absence of comprehensive studies exploring the relationships of LEP and ADPN with the anthropometric indices and behavioral and physical performances of Chinese college students, our present study is the first work to provide such information. LEP and ADPN are inversely correlated in obesity. The major finding of our study is a quasiperfect (r = 0.961, p = 0.000) correlation between LEP and ADPN. This result is surprising because LEP and ADPN have an inverse relationship in humans [32,55,56,57,60]. Given that we did not find any study on a similar cohort (age and ethnicity), we can hypothesize that this result can be attributed to diet. In fact, all of our subjects attend the same university and may share common dietary factors that influence ADPN levels. Although our sample size is relatively small, the subjects are highly homogeneous, all being college students of the same age and gender (with the exception of three females). They also consume their meals at the same place and sleep in dormitories under similar conditions. We can hypothesize that some factors can influence the strong correlation that we found between LEP and ADPN. For example, the consumption of green tea is common among Chinese students and could reduce LEP and increase ADPN considerably [61]. Moreover, the students live in Shanghai, wherein the local diet is rich in fish omega-3, which can also reduce LEP [62]. Another possible explanation for the strong correlation between LEP and ADPN may be the distribution of body fat in the Asian biotype [4]. Such a distribution is associated with the differing secretion of LEP and ADPN in the blood stream. Asians accumulate more visceral fat tissue and less subcutaneous fat than Caucasians. Although the association of LEP and ADPN with muscle mass (fat-free mass) and lower limb strength was previously observed in young tennis players [63] and Chinese high school students [64], it remains controversial. A previous work found that LEP was positively associated with muscle density (it would decrease skeletal muscle lipid content and promote lipid oxidation) [65], whereas another study discovered that LEP was negatively correlated with muscle density and relative hand grip strength [66]. In contrast to a study on young Caucasians [66] and Afro-Americans [67], our work found that hand strength was positively correlated with LEP. Our study also discovered a relationship between LEP/ADPN and abdominal strength. The correlation with muscle mass and thus with strength can be explained by the involvement of ADPN in the phosphorylation of adenosine monophosphate, which acts as a signaling factor in skeletal muscles [68].
We investigated the behavioral characteristics associated with LEP/ADNP. Although an association exists between feeding and LEP levels [69], we did not find such an association in our subjects. The relationship between high levels of LEP and sleep found in previous studies [70] could not be observed in our work. The LEP level in our sample was five times lower than that normally present in the obese Caucasian population [71]. Although a certain degree of this difference can be explained by the sensitivity of measurement methods, our Chinese samples had very low LEP levels. Our work found that LEP and ADPN were associated with depression and stress, confirming the findings in the Caucasian population [72]. Given that LEP and ADPN are also ergogenic [73], their association with the PF index measured by using the SF questionnaire is unsurprising. We hypothesize that the association with BP can be attributed to LEP-associated inflammation in obese individuals, as shown in a previous study [74]. However, the association of ADPN with pain remains under debate [75]. These factors could have contributed to the low levels of LEP and strong association between LEP and ADPN in our study. We discovered a correlation between ADPN and selected body dimensions (BMI; height; hip, biceps (contracted and relaxed), waist, and calf circumferences; shoulder crease skinfolds; waist:hip ratio and muscle mass). This result is in agreement with the hypertrophic role of ADPN [76]. In fact, ADPN was also correlated with muscle and fat-free masses, 1 min squat (reps), long jump, 1 min sit-up (reps), and hand grip but not with sit-and-reach test results and body balance. LEP presented correlations with previous variables, except for muscle mass, fat-free mass, waist circumferences, and shoulder crease skinfold. However, in contrast to ADPN, LEP showed a correlation with thigh circumference in agreement with the secretion of LEP by subcutaneous fat tissues [1]. A limitation of our study is that we did not measure visceral fat, which is highly correlated with LEP and inversely correlated with ADPN. In addition, diet was not assessed in detail, and we did not include a control group (which could have been helpful in strengthening the results). Our sample is also unbalanced in gender distribution. We are aware that our number of participants is limited and imbalanced. However, the incidence of obesity in China is considerably lower than in Western countries, and our sample included almost all of the obese students of the campus.

5. Conclusions

Our study found new relationships of LEP and ADPN with selected anthropometric and behavioral variables in obese Chinese college students. These correlations are different from those observed previously in the Caucasian population and deserve further investigation. We hypothesize that our results can be attributed to differences in diets. The relationships of LEP and ADPN with anthropometric and biochemical indices, performance, and mood indicate that LEP/ADPN has a relationship with selected anthropometric indices, mood states, and physical performance in overweight and obese Chinese college students.

Author Contributions

Conceptualization, A.C. and J.S.; experimental operation, J.C.; data curation, J.C.; writing—original draft preparation, A.C., J.C. and J.S.; writing—review and editing, A.C. and J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (No. 32071172 and nr. ALA220029).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee) of Tongji University (protocol code 2021tjdx024 of 2 March 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Due to privacy reasons, the datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Acknowledgments

The authors thank the participants for their contributions to this work.

Conflicts of Interest

The authors declare that they have no competing interests.

References

  1. Friedman, J.M.; Halaas, J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395, 763–770. [Google Scholar] [CrossRef]
  2. Zhang, Y.; Chua, S., Jr. Leptin function and regulation. Compr. Physiol. 2011, 8, 351–369. [Google Scholar]
  3. Fang, H.; Judd, R.L. Adiponectin regulation and function. Compr. Physiol. 2011, 8, 1031–1063. [Google Scholar]
  4. Aisike, G.; Kuerbanjiang, M.; Muheyati, D.; Zaibibuli, K.; Lv, M.X.; Han, J. Correlation analysis of obesity phenotypes with leptin and adiponectin. Sci. Rep. 2023, 13, 17718. [Google Scholar] [CrossRef] [PubMed]
  5. Zurita-Cruz, J.N.; Villasís-Keever, M.A.; Manuel-Apolinar, L.; Damasio-Santana, L.; Garrido-Magaña, E.; Rivera-Hernández, A.D.J. Leptin/adiponectin ratio as a prognostic factor for increased weight gain in girls with central precocious puberty. Front. Endocrinol. 2023, 14, 1101399. [Google Scholar] [CrossRef]
  6. Hou, N.; Luo, J.D. Leptin and cardiovascular diseases. Clin. Exp. Pharmacol. Physiol. 2011, 38, 905–913. [Google Scholar] [CrossRef] [PubMed]
  7. Vatier, C.; Barbara, A.P.; Fellahi, S.; Vigouroux, C.; Capeau, J.; Bastard, J.P. Le rapport adiponectine sur leptine, un biomarqueur d’insulino-résistance et de risque cardiométabolique encore méconnu. Ann. Biol. Clin. 2020, 78, 265–268. [Google Scholar]
  8. Ye, Y.; Wu, P.; Wang, Y.; Yang, X.; Ye, Y.; Yuan, J.; Pan, A. Adiponectin, leptin, and leptin/adiponectin ratio with risk of gestational diabetes mellitus: A prospective nested case-control study among Chinese women. Diabetes Res. Clin. Pract. 2022, 191, 110039. [Google Scholar] [CrossRef]
  9. Marques-Vidal, P.; Bochud, M.; Paccaud, F.; Mooser, V.; Waeber, G.; Vollenweider, P. Distribution of plasma levels of adiponectin and leptin in an adult Caucasian population. Clin. Endocrinol. 2010, 72, 38–46. [Google Scholar] [CrossRef]
  10. Conroy, S.M.; Chai, W.; Lim, U.; Franke, A.A.; Cooney, R.V.; Maskarinec, G. Leptin, adiponectin, and obesity among Caucasian and Asian women. Mediat. Inflamm. 2011, 2011, 253580. [Google Scholar] [CrossRef]
  11. Guan, Y.; Zuo, F.; Zhao, J.; Nian, X.; Shi, L.; Xu, Y.; Wu, B. Relationships of adiponectin to regional adiposity, insulin sensitivity, serum lipids, and inflammatory markers in sedentary and endurance-trained Japanese young women. Front. Endocrinol. 2023, 14, 1097034. [Google Scholar] [CrossRef] [PubMed]
  12. Sun, C.; Kovacs, P.; Guiu-Jurado, E. Genetics of body fat distribution: Comparative analyses in populations with European, Asian and African ancestries. Genes 2021, 12, 841. [Google Scholar] [CrossRef] [PubMed]
  13. Lear, S.A.; Humphries, K.H.; Kohli, S.; Chockalingam, A.; Frohlich, J.J.; Birmingham, C.L. Visceral adipose tissue accumulation differs according to ethnic background: Results of the Multicultural Community Health Assessment Trial (M-CHAT). Am. J. Clin. Nutr. 2007, 86, 353–359. [Google Scholar] [CrossRef] [PubMed]
  14. Tanaka, S.; Horimai, C.; Katsukawa, F. Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: A meta-analysis. Acta Diabetol. 2003, 40, s302–s304. [Google Scholar] [CrossRef] [PubMed]
  15. Cicchella, A.; Jurimae, T.; Stefanelli, C.; Purge, P.; Saar, M. Correlations of skinfold thicknesses and circumferences at exactly defined body sites with leptin in 10–12-year-old boys with different BMIs. Coll. Antropol. 2014, 38, 459–465. [Google Scholar] [PubMed]
  16. Wada, N.; Hirako, S.; Takenoya, F.; Kageyama, H.; Okabe, M.; Shioda, S. Leptin and its receptors. J. Chem. Neuroanat. 2014, 61, 191–199. [Google Scholar] [CrossRef] [PubMed]
  17. Roubos, E.W.; Dahmen, M.; Kozicz, T.; Xu, L. Leptin and the hypothalamo-pituitary–adrenal stress axis. Gen. Comp. Endocrinol. 2012, 177, 28–36. [Google Scholar] [CrossRef] [PubMed]
  18. Jin, H.; Meyer, J.M.; Mudaliar, S.; Jeste, D.V. Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr. Res. 2008, 100, 70–85. [Google Scholar] [CrossRef]
  19. Otsuka, R.; Yatsuya, H.; Tamakoshi, K.; Matsushita, K.; Wada, K.; Toyoshima, H. Perceived Psychological Stress and Serum Leptin Concentrations in Japanese Men. Obesity 2006, 14, 1832–1838. [Google Scholar] [CrossRef]
  20. Tomiyama, A.J. Stress and obesity. Annu. Rev. Psychol. 2019, 70, 703–718. [Google Scholar] [CrossRef]
  21. Carvalho, A.F.; Rocha, D.Q.; McIntyre, R.S.; Mesquita, L.M.; Koehler, C.A.; Hyphantis, T.N.; Berk, M. Adipokines as emerging depression biomarkers: A systematic review and meta-analysis. J. Psychiatr. Res. 2014, 59, 28–37. [Google Scholar] [CrossRef] [PubMed]
  22. Scott, S.R.; Millwood, S.N.; Manczak, E.M. Adipocytokine correlates of childhood and adolescent mental health: A systematic review. Dev. Psychobiol. 2023, 65, e22379. [Google Scholar] [CrossRef] [PubMed]
  23. Comeras, L.B.; Herzog, H.; Tasan, R.O. Neuropeptides at the crossroad of fear and hunger: A special focus on neuropeptide Y. Ann. N. Y. Acad. Sci. 2019, 1455, 59–80. [Google Scholar] [CrossRef] [PubMed]
  24. Beccuti, G.; Pannain, S. Sleep and obesity. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 402–412. [Google Scholar] [CrossRef] [PubMed]
  25. Mota, G.R.D.; Zanesco, A. Leptin, ghrelin, and physical exercise. Arq. Bras. Endocrinol. Metabol. 2007, 51, 25–33. [Google Scholar] [CrossRef]
  26. Kraemer, R.R.; Chu, H.; Castracane, V.D. Leptin and exercise. Exp. Biol. Med. 2002, 227, 701–708. [Google Scholar] [CrossRef] [PubMed]
  27. Voss, S.C.; Nikolovski, Z.; Bourdon, P.C.; Alsayrafi, M.; Schumacher, Y.O. The effect of cumulative endurance exercise on leptin and adiponectin and their role as markers to monitor training load. Biol. Sport 2016, 33, 23–28. [Google Scholar] [PubMed]
  28. Cicchella, A.; Stefanelli, C.; Jürimäe, T.; Saar, M.; Purge, P. Moderate physical activity correlates with elevated leptin in physically active 10–12-year-old boys with normal BMI. Percept. Mot. Skills 2013, 117, 358–366. [Google Scholar] [CrossRef] [PubMed]
  29. Gullu, E.; Gullu, A.; Düzova, H.; Ozgor, B.İ.L.G.E.; Kilinç, E.; Akçinar, F. The relationship between serum leptin and VO2max levels in pre-puberty swimmer girls: Effect of acute exercise. Prog. Nutr. 2020, 22, 177–184. [Google Scholar]
  30. van Niekerk, E.; Botha-Le Roux, S.; Mels, C.M.; Swanepoel, M.; Delles, C.; Welsh, P.; Kruger, R. Twenty-four-hour ambulatory, but not clinic blood pressure associates with leptin in young adults with overweight or obesity: The African-PREDICT study. Hypertens. Res. 2024, 47, 478–486. [Google Scholar] [CrossRef]
  31. Sigit, F.S.; Trompet, S.; Tahapary, D.L.; Sartono, E.; van Dijk, K.W.; Yazdanbakhsh, M.; de Mutsert, R. The associations of leptin and adiponectin with the metabolic syndrome in an Indonesian and a Dutch population. Nutr. Metab. Cardiovasc. Dis. 2021, 31, 2426–2435. [Google Scholar] [CrossRef] [PubMed]
  32. Baratta, R.; Amato, S.; Degano, C.; Farina, M.G.; Patanè, G.; Vigneri, R.; Frittitta, L. Adiponectin relationship with lipid metabolism is independent of body fat mass: Evidence from both cross-sectional and intervention studies. J. Clin. Endocrinol. Metab. 2004, 89, 2665–2671. [Google Scholar] [CrossRef] [PubMed]
  33. Morrison, C.D. Leptin signaling in brain: A link between nutrition and cognition? Biochim. Biophys. Acta Mol. Basis Dis. 2009, 1792, 401–408. [Google Scholar] [CrossRef] [PubMed]
  34. Li, G.; Feng, D.; Qu, X.; Fu, J.; Wang, Y.; Li, L.; Gao, S. Role of adipokines FGF21, leptin and adiponectin in self-concept of youths with obesity. Eur. Neuropsychopharmacol. 2018, 28, 892–902. [Google Scholar] [CrossRef] [PubMed]
  35. Pan, W.; Kastin, A.J. Leptin: A biomarker for sleep disorders? Sleep Med. Rev. 2014, 18, 283–290. [Google Scholar] [CrossRef] [PubMed]
  36. Wu, Y.T.; Huang, W.Y.; Kor, C.T.; Liu, K.H.; Chen, T.Y.; Lin, P.T.; Wu, H.M. Relationships between depression and anxiety symptoms and adipocyte-derived proteins in postmenopausal women. PLoS ONE 2021, 16, e0248314. [Google Scholar] [CrossRef] [PubMed]
  37. Bouillon-Minois, J.B.; Trousselard, M.; Thivel, D.; Benson, A.C.; Schmidt, J.; Moustafa, F.; Dutheil, F. Leptin as a biomarker of stress: A systematic review and meta-analysis. Nutrients 2021, 13, 3350. [Google Scholar] [CrossRef] [PubMed]
  38. Overvad, K.I.M.; Jønneland, A.T.; Haraldsdóttir, J.; Ewertz, M.; Jensen, O.M. Development of a semiquantitative food frequency questionnaire to assess food, energy and nutrient intake in Denmark. Int. J. Epidemiol. 1991, 20, 900–905. [Google Scholar] [CrossRef] [PubMed]
  39. Craig, C.L.; Marshall, A.L.; Sjöström, M. International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 2003, 35, 1381–1395. [Google Scholar] [CrossRef]
  40. Guidelines for the Prevention and Control of Overweight and Obesity in Chinese Adults (Trial). Issued by the Department of Disease Control and Prevention of the National Health and Family Planned parenthood Commission. 2003. Available online: https://pubmed.ncbi.nlm.nih.gov/15807475/ (accessed on 21 May 2024).
  41. Norton, K. Standards for Anthropometry Assessment. In Kinanthropometry and Exercise Physiology; Routledge: New York, NY, USA, 2018; pp. 68–137. [Google Scholar]
  42. ACSM’s Guidelines for Exercise Testing and Prescription, 11th ed.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2021.
  43. Tan, S.; Wang, J.; Cao, L. Exercise training at the intensity of maximal fat oxidation in obese boys. Appl. Physiol. Nutr. Metab. 2016, 41, 49–54. [Google Scholar] [CrossRef]
  44. Wang, Y.; Guo, X.; Liu, L.; Xie, M.; Lam, W.K. Effects of Tai-chi and running exercises on cardiorespiratory fitness and biomarkers in sedentary middle-aged males: A 24-week supervised training study. Biology 2022, 11, 375. [Google Scholar] [CrossRef] [PubMed]
  45. Lins, L.; Carvalho, F.M. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016, 4, 2050312116671725. [Google Scholar] [CrossRef] [PubMed]
  46. Alomari, M.A.; Keewan, E.F.; Qhatan, R.; Amer, A.; Khabour, O.F.; Maayah, M.F.; Hurtig-Wennlöf, A. Blood pressure and circulatory relationships with physical activity level in young normotensive individuals: IPAQ validity and reliability considerations. Clin. Exp. Hypertens. 2011, 33, 345–353. [Google Scholar] [CrossRef] [PubMed]
  47. Thompson, E. Hamilton rating scale for anxiety (HAM-A). Occup. Med. 2015, 65, 601. [Google Scholar] [CrossRef] [PubMed]
  48. Leung, C.M.; Wing, Y.K.; Kwong, P.K.; Shum, A.L.K. Validation of the Chinese-Cantonese version of the Hospital Anxiety and Depression Scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatr. Scand. 1999, 100, 456–461. [Google Scholar] [CrossRef] [PubMed]
  49. Meng, R.; Li, J.; Wang, Z.; Zhang, D.; Liu, B.; Luo, Y.; Yu, C. The Chinese version of the Perceived Stress Questionnaire: Development and validation amongst medical students and workers. Health Qual. Life Outcomes 2022, 18, 70. [Google Scholar] [CrossRef] [PubMed]
  50. Sepehry, A.A. Self-rating depression scale (SDS). In Encyclopedia of Quality of Life and Well-Being Research; Springer International Publishing: Cham, Switzerland, 2024; pp. 6269–6276. [Google Scholar]
  51. Cappelleri, J.C.; Bushmakin, A.G.; Gerber, R.A.; Leidy, N.K.; Sexton, C.C.; Lowe, M.R.; Karlsson, J. Psychometric analysis of the Three-Factor Eating Questionnaire-R21: Results from a large diverse sample of obese and non-obese participants. Int. J. Obes. 2009, 33, 611–620. [Google Scholar] [CrossRef] [PubMed]
  52. Zhang, T.; Hao, Y.; Yuan, H.; Bu, P. Validity and reliability of Chinese version of Three-Factor Eating Questionnaire R21 for assessment of sample of college students. Chin. Nurs. Res. 2016, 30, 4137–4141. [Google Scholar]
  53. Shi, C.; Guo, Y.; Ma, H.; Zhang, M. Psychometric validation of the 14-item perceived stress scale in Chinese medical residents. Curr. Psychol. 2019, 38, 1428–1434. [Google Scholar] [CrossRef]
  54. Guo, S.; Sun, W.; Liu, C.; Wu, S. Structural validity of the Pittsburgh sleep quality index in Chinese undergraduate students. Front. Psychol. 2016, 7, 1126. [Google Scholar] [CrossRef]
  55. Diamond, F.B., Jr.; Cuthbertson, D.; Hanna, S.; Eichler, D. Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J. Pediatr. Endocrinol. Metab. 2004, 17, 1069–1076. [Google Scholar] [CrossRef]
  56. Salimi, S.; Farajian-Mashhadi, F.; Naghavi, A.; Mokhtari, M.; Shahrakipour, M.; Saravani, M.; Yaghmaei, M. Different profile of serum leptin between early onset and late onset preeclampsia. Dis. Markers 2014, 2014, 628476. [Google Scholar] [CrossRef] [PubMed]
  57. Pardo, I.M.; Geloneze, B.; Tambascia, M.A.; Barros-Filho, A.A. Hyperadiponectinemia in newborns: Relationship with leptin levels and birth weight. Obes. Res. 2004, 12, 521–524. [Google Scholar] [CrossRef] [PubMed]
  58. Paduszyńska, A.; Sakowicz, A.; Banach, M.; Maciejewski, M.; Dąbrowa, M.; Bielecka-Dąbrowa, A. Cardioprotective properties of leptin in patients with excessive body mass. Ir. J. Med. Sci. 2020, 189, 1259–1265. [Google Scholar] [CrossRef] [PubMed]
  59. Wang, H.; Necheles, J.; Birne, J.S.; Li, Z.; Xing, H.; Tang, G.; Christoffel, K.K.; Brickman, W.J.; Zimmerman, D.; Wang, X. Association of adipokines with blood pressure in rural Chinese adolescents. J. Hum. Hypertens. 2012, 26, 493–501. [Google Scholar] [CrossRef] [PubMed]
  60. Izadi, V.; Larijani, B.; Azadbakht, L. Is coffee and green tea consumption related to serum levels of adiponectin and leptin? Int. J. Prev. Med. 2018, 9, 106. [Google Scholar] [PubMed]
  61. Enomoto, N.; Oyama, Y.; Yasui, H.; Karayama, M.; Hozumi, H.; Suzuki, Y.; Kono, M.; Furuhashi, K.; Fujisawa, T.; Inui, N.; et al. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis. Sci. Rep. 2019, 9, 10484. [Google Scholar] [CrossRef] [PubMed]
  62. Winnicki, M.; Somers, V.K.; Accurso, V.; Phillips, B.G.; Puato, M.; Palatini, P.; Pauletto, P. Fish-rich diet, leptin, and body mass. Circulation 2022, 106, 289–291. [Google Scholar] [CrossRef]
  63. Olmedillas, H.; Sanchis-Moysi, J.; Fuentes, T.; Guadalupe-Grau, A.; Ponce-González, J.G.; Morales-Alamo, D.; Santana, A.; Dorado, C.; Calbet, J.A.; Guerra, B. Muscle hypertrophy and increased expression of leptin receptors in the musculus triceps brachii of the dominant arm in professional tennis players. Eur. J. Appl. Physiol. 2010, 108, 749–758. [Google Scholar] [CrossRef]
  64. Adelantado-Renau, M.; Jiménez-Pavón, D.; Beltran-Valls, M.R.; Ponce-González, J.G.; Chiva-Bartoll, Ó.; Moliner-Urdiales, D. Fitness and academic performance in adolescents. The mediating role of leptin: DADOS study. Eur. J. Pediatr. 2018, 177, 1555–1563. [Google Scholar] [CrossRef]
  65. Muñoz, J.; Gower, B.A. Relationship between serum leptin concentration and low-density muscle in postmenopausal women. J. Clin. Endocrinol. Metab. 2003, 88, 1157–1161. [Google Scholar] [CrossRef] [PubMed]
  66. Gysel, T.; Tonoli, C.; Pardaens, S.; Cambier, D.; Kaufman, J.M.; Zmierczak, H.G.; Goemaere, S.; Lapauw, B.; Calders, P. Lower insulin sensitivity is related to lower relative muscle cross-sectional area, lower muscle density and lower handgrip force in young and middle aged non-diabetic men. J. Musculoskelet. Neuronal Interact. 2016, 16, 302–309. [Google Scholar] [PubMed]
  67. Perry, H.M.; Miller, D.K.; Patrick, P.; Morley, J.E. Testosterone and leptin in older African-American men: Relationship to age, strength, function, and season. Metabolism 2000, 49, 1085–1091. [Google Scholar] [CrossRef] [PubMed]
  68. Díez, J.J.; Iglesias, P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 2003, 148, 293–300. [Google Scholar] [CrossRef] [PubMed]
  69. Pénicaud, L.; Meillon, S.; Brondel, L. Leptin and the central control of feeding behavior. Biochimie 2012, 94, 2069–2074. [Google Scholar] [CrossRef] [PubMed]
  70. Hebebrand, J.; Denecke, S.; Antel, J. The role of leptin in rodent and human sleep: A transdiagnostic approach with a particular focus on anorexia nervosa. Neurosci. Biobehav. Rev. 2023, 149, 105164. [Google Scholar] [CrossRef] [PubMed]
  71. Dahmen, N.; Engel, A.; Helfrich, J.; Manderscheid, N.; Löbig, M.; Forst, T.; Pfützner, A.; Tonn, P. Peripheral leptin levels in narcoleptic patients. Diabetes Technol. Ther. 2007, 9, 348–353. [Google Scholar] [CrossRef] [PubMed]
  72. Milaneschi, Y.; Simmons, W.K.; van Rossum, E.F.; Penninx, B.W. Depression and obesity: Evidence of shared biological mechanisms. Mol. Psychiatry 2019, 24, 8–33. [Google Scholar] [CrossRef]
  73. Nieman, D.C.; Stear, S.J.; Castell, L.M.; Burke, L.M. A-Z of nutritional supplements: Dietary supplements, sports nutrition foods and ergogenic aids for health and performance: Part 24. Br. J. Sports Med. 2011, 45, 1005–1007. [Google Scholar]
  74. Soares Bonato, R.C.; Abel Mapengo, M.A.; de Azevedo-Silva, L.J.; Janson, G.; de Carvalho Sales-Peres, S.H. Tooth movement, orofacial pain, and leptin, interleukin-1β, and tumor necrosis factor-α levels in obese adolescents. Angle Orthod. 2022, 92, 95–100. [Google Scholar] [CrossRef]
  75. Peterlin, B.L.; Sacco, S.; Bernecker, C.; Scher, A.I. Adipokines and migraine: A systematic review. Headache 2016, 56, 622–644. [Google Scholar] [CrossRef] [PubMed]
  76. Tanaka, Y.; Kita, S.; Nishizawa, H.; Fukuda, S.; Fujishima, Y.; Obata, Y.; Shimomura, I. Adiponectin promotes muscle regeneration through binding to T-cadherin. Sci. Rep. 2019, 9, 16. [Google Scholar] [CrossRef] [PubMed]
Table 1. Anthropometrics, biochemical, cardiorespiratory indices, and functional measures (mean and standard deviation).
Table 1. Anthropometrics, biochemical, cardiorespiratory indices, and functional measures (mean and standard deviation).
MeanSDRange
Anthropometrics
Height (cm)176.92±6.62167.00–180.7
Weight (kg)86.75±20.4665.60–142.10
BMI29.28±5.4824.100–40.40
Fat-free mass (kg)61.43±13.6041.30–87.90
Fat mass (kg)26.75±11.8112.10–61.10
Muscle mass (kg)58.4±42554.80–53.10
Body fat %24.2±6.5317.30–30.30
Waist:hip ratio0.94±0.040.91–0.98
Chest circum (cm)95.143±19.73101–123.00
Waistline (cm)93±13.1278.50–129.00
Minimum waist circum (cm)88.98±10.1673.20–116.00
Hipline (cm)99.98±20.8791.00–106.00
Thigh circum (cm)62.9±7.1653.00–78.00
Calf circum (cm)41.75±4.1436.00–52.00
Biceps contract circum (cm)32.07±4.3224.4–44.00
Biceps relaxed circum (cm)30.91±3.4224.80–37.00
Abdominal skinfold (mm)48.90±19.6419.50–75.00
Shoulder crease skinfold (mm)33.89±10.9713.00–53.00
Biceps skinfold (mm)39.51±13.7512.00–73.00
Thigh crease skinfold (mm)50.14±19.268.00–75.00
Iliac skinfold (mm)24.53±12.525.00–51.00
Calf skinfold (mm)34.093±13.8112.00–56.00
Biochemical parameters
TC (mM/L)4.03±0.921.87–5.67
TG (mM/mL)1.14±0.570.27–2.84
HDL (mM/L)1.35±0.250.79–1.85
LDL (mM/L)2.59±0.780.70–4.28
Glucose (mM/L)4.76±0.343.88–5.59
LEP (ng/mL)3.83±0.822.50–5.42
ADPN (mg/L)8.69±1.825.58–12.31
ADPN/LEP ratio2.30±0.112.07–2.48
HGB (mM/L)82.66±8.4466.55–100.38
HbA1c (mM/L)32.28±16.1419.72–98.49
Cardiorespiratory indices
Basal VO2 (L/min)1822±157.041688–1995
VO2 max (L/min)3374.27±1016.871222–5889
VO2 max (mL/Kg/min)40.46±5.8830.90–53.40
METS11.71±2.474.40–17.50
Physical performance parameters
Systolic pressure (mmHg)128.96±22.3595.00–157.00
Diastolic pressure (mmHg)76.38±10.0163.00–97.00
Resting heart rate (beats/min)80.44±13.7354.00–101.00
Hand grip strength (right hand) (kg)37.64±9.2319.30–61.90
Vital capacity (mL)3878.69±913.542674–7140
Sit-and-reach (cm)+14.05±8.58−2.90–(+)29.00
1 min sit-ups (number)30.81±6.2218.00–45.00
Standing long jump (cm)195.712 ± 5.71144.00–243.00
1 min squats (number)48.389 ± 0.7131.00–65.00
Standing on one leg with eyes closed (s)33.95±32.371.20–131.53
BMI: body mass index; TC: total cholesterol; TG: triglyceride; HDL: high-density lipoprotein; LDL: low-density lipoprotein cholesterol; HGB: hemoglobin; LEP: leptin; ADPN: adiponectin. In the sit-and-reach test, 0 is the feet line, + is beyond the feet line, − is before the feet line.
Table 2. Questionnaires scores (mean and standard deviation).
Table 2. Questionnaires scores (mean and standard deviation).
MeanSDRange
SF-36
PF66.12±39.8570–100
RP77.93±17.6125–100
BP52.38±13.5441–90
GH65.2±21.1930–92
VT82.98±21.4515–90
SF41.51±32.3544.44–100.00
RE67.28±21.0833–100
MH56.01±30.5832–96
HT54.46±25.5125–100
IPAQ
JOB1057±1024.55330–3816
Transport1083.16±1029.71198–3312
House work139.82±231.9160–1080
Recovery714.17±1026.0323–3876
MET2642.8±1864.69442.2–8544.0
Walk1402.63±1447.3582.5–5841.0
Medium intensity991.96±760.6260–2940
High intensity779.43±653.57120–2520
PSS43.85±4.2434–56
SDS29.46±6.8720–47
TFEQR-21
Uncontrolled eating18.46±4.9011–31
Restrain15.07±4.898–26
Emotional eating12.30±5.884–25
FS-14
Physical fatigue3.73±2.062–8
Mental fatigue2.57±1.831–6
Total score7.30±3.261–12
PSQI5.5±2.701–13
HAMA
Mental anxiety5.84±4.640–16
Body anxiety4.69±2.710–12
Total score10.53±6.152–2618
SF-36: The 36-Item Short Form Health Survey questionnaire; PF: physical function; RP: physical role; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: emotional role; MH: mental health; HT health changes in the past year; PSS: perceived stress scale; SDS: stress depression scale; IPAQ: international physical activity scale; TFEQR-21: Three Factor Eating Questionnaire-R21; FS-14: Fatigue Scale-14; PSQI: Pittsburgh Sleep Quality Index; HAMA: Hamilton Anxiety Scale.
Table 3. Correlations of LEP and ADPN with biochemical parameters, anthropometry, functional indices, and questionnaires.
Table 3. Correlations of LEP and ADPN with biochemical parameters, anthropometry, functional indices, and questionnaires.
LEPADPN
rprp
Biochemical parametersGlucose0.6070.0010.6260.000
TC−0.5010.0000.8120.000
TG0.3770.0060.5470.003
HDLn.s.n.s.0.4980.007
LDL0.6020.000n.sn.s.
HGB0.7090.0000.5450.003
HbA1c0.2830.042n.s.n.s.
BMI0.4190.0260.4380.02
Hip circum0.4870.0090.4710.11
AnthropometryHeight0.5310.0040.5490.002
Muscle massn.s.n.s.0.3880.041
Fat-free massn.s.n.s.0.390.04
Biceps control0.4140.0160.4740.011
Biceps relaxed0.4910.0080.5020.006
Calf circum0.50.0070.5040.006
Shoulder crease skinn.s.n.s.0.3840.044
Waist:hip0.5850.0010.6080.001
Waist circumn.s.n.s.0.520.005
Thigh circum0.5330.003n.s.n.s.
Functional indices1 min-squat (reps)0.3750.0490.4160.028
Long jump0.450.0160.490.008
Hand grip0.3470.0710.3980.036
1 min sit-ups0.3620.0580.3890.041
Systolic pressure0.5810.0020.5990.001
Diastolic pressure0.5970.0010.5750.002
METS0.4160.0280.4280.023
QuestionnairesSDS total0.470.0120.4860.009
PSS totaln.s.n.s.0.5380.003
SF36/bp0.5460.0030.5460.003
SF36/pf0.3790.0470.4160.028
PSQI0.2880.0390.5380.003
TC: total cholesterol; TG: triglyceride; HDL: high-density lipoprotein; LDL: low-density lipoprotein cholesterol; HGB: hemoglobin; SDS: stress depression scale; PSS: perceived stress scale; SF36/bp: bodily pain; SF36/pf: physical functioning; PSQI: Pittsburgh Sleep Quality Index. n.s. = nonsignificant.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sun, J.; Chen, J.; Cicchella, A. Correlation of Adiponectin and Leptin with Anthropometrics and Behavioral and Physical Performance in Overweight and Obese Chinese College Students. Biology 2024, 13, 567. https://doi.org/10.3390/biology13080567

AMA Style

Sun J, Chen J, Cicchella A. Correlation of Adiponectin and Leptin with Anthropometrics and Behavioral and Physical Performance in Overweight and Obese Chinese College Students. Biology. 2024; 13(8):567. https://doi.org/10.3390/biology13080567

Chicago/Turabian Style

Sun, Jingyu, Jiajia Chen, and Antonio Cicchella. 2024. "Correlation of Adiponectin and Leptin with Anthropometrics and Behavioral and Physical Performance in Overweight and Obese Chinese College Students" Biology 13, no. 8: 567. https://doi.org/10.3390/biology13080567

APA Style

Sun, J., Chen, J., & Cicchella, A. (2024). Correlation of Adiponectin and Leptin with Anthropometrics and Behavioral and Physical Performance in Overweight and Obese Chinese College Students. Biology, 13(8), 567. https://doi.org/10.3390/biology13080567

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop